Industry Reports

Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has analyzed data from 209,860 hepatitis B (HBV) and C (HCV) patients, from 940 trial arms/cohorts to build a picture of the “typical” patient and identify...

Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantly driving up demand and prices for mergers and acquisitions. The full findings (featuring 10+ experts...

Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released the results of its global drug delivery and packaging survey, with the USA once again leading ‘drug delivery and device innovation’, but lagging behind...

Sales grow by 35.0% to CHF 239.1 million EBITDA rises from CHF 53.0 million to CHF 75.5 million and a margin of 31.6%. Operating income (EBIT) increases from CHF 40.3 million to CHF 61.9 million and a margin...

Samsung Biologics , a leading contract development and manufacturing organization, announced strong financial results for the secondquarter of fiscal 2021. John Rim, CEO of Samsung Biologics, stated, “The second-quarter financial performance demonstrates our ability to maintain steady operations despite the...

Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company’s policies for an enhanced ESG management system and related plans. The report focuses on the company’s commitment to taking...

Virtual clinical development specialist, Phesi Inc., has today released findings from a significant analysis of COVID-19 patient profiles; based on data from 166,239 COVID-19 patients, from 523 cohorts/trial arms. The data includes patients from 56 countries, including the USA,...